American Oncology Network, Inc.: share-based compensation expense
Share-based compensation expense for American Oncology Network, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All American Oncology Network, Inc. financial histories
What this measure means
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
Exact concept: us-gaap:ShareBasedCompensation. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-01-01 | 2024-12-31 | 14,422,000 | USD | 2025-03-27 | 10-K · 0001628280-25-015237 |
| 2023-01-01 | 2023-12-31 | 4,874,000 | USD | 2025-03-27 | 10-K · 0001628280-25-015237 |
| 2022-01-01 | 2022-12-31 | 0 | USD | 2024-03-28 | 10-K · 0001839998-24-000021 |
| 2021-01-01 | 2021-12-31 | 20,000 | USD | 2024-03-28 | 10-K · 0001839998-24-000021 |
Related financial histories
- American Oncology Network, Inc.: total assets
- American Oncology Network, Inc.: total liabilities
- American Oncology Network, Inc.: stockholders equity
- American Oncology Network, Inc.: cash and cash equivalents
- American Oncology Network, Inc.: operating cash flow
- American Oncology Network, Inc.: capital expenditure payments
- American Oncology Network, Inc.: contract revenue excluding tax
- American Oncology Network, Inc.: financing cash flow
- American Oncology Network, Inc.: investing cash flow
- American Oncology Network, Inc.: retained earnings or deficit
- American Oncology Network, Inc.: basic weighted-average shares
- American Oncology Network, Inc.: diluted weighted-average shares
- American Oncology Network, Inc.: basic earnings per share
- American Oncology Network, Inc.: diluted earnings per share
- American Oncology Network, Inc.: income tax expense or benefit
- American Oncology Network, Inc.: operating income or loss
- American Oncology Network, Inc.: current assets
- American Oncology Network, Inc.: interest expense
- American Oncology Network, Inc.: current liabilities
- American Oncology Network, Inc.: current accounts payable
- American Oncology Network, Inc.: net current accounts receivable
- American Oncology Network, Inc.: common-stock repurchase payments
- American Oncology Network, Inc.: net inventory
- American Oncology Network, Inc.: cost of revenue
Inspect the source
- Entity
- American Oncology Network, Inc. / CIK 0001839998
- Captured
- 2026-09-21T17:31:11.929Z
- SEC response SHA-256
10bec7bfe15214c31433dc7c662bac61079548b5892e2984769197e071b63400
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001839998.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))